Position in AMGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$878,865
+$22,463 QoQ
Shares Held
2,427
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#1,785
of 3,140 holders
Holding Since
Sep 2020
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MAGNOLIA CAPITAL ADVISORS LLC holds $19,446,017 across 8 Drug Manufacturers - General names. AMGN ranks #5 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,906 | $5,884,404 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,718 | $4,461,263 | |
| 3 | ABBV |
AbbVie Inc.
|
16,722 | $4,207,924 | |
| 4 | JNJ |
Johnson & Johnson
|
11,815 | $3,000,655 | |
| 5 | AMGN |
Amgen Inc
This page
|
2,427 | $878,865 | |
| 6 | PFE |
Pfizer Inc
|
16,265 | $391,661 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,020 | $381,546 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,160 | $239,699 |
All Filings in AMGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $878,865 | 2,427 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $856,402 | 2,434 | Shares | Sole | 2026-05-15 | |
| 2024-12-31 | $243,698 | 935 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $287,411 | 892 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $208,404 | 667 | Shares | Sole | 2024-10-30 | |
| 2021-03-31 | $872,079 | 3,505 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $257,740 | 1,121 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $240,181 | 945 | Shares | Sole | 2020-11-02 | |
| No filing history on record for this holder in this stock. | ||||||